Surgical Science Sweden AB (publ) (STO: SUS)
Sweden
· Delayed Price · Currency is SEK
123.60
-0.40 (-0.32%)
Sep 2, 2024, 9:38 AM CET
SUS Revenue
Surgical Science Sweden AB had revenue of 212.47M SEK in the quarter ending June 30, 2024, a decrease of -1.74%. This brings the company's revenue in the last twelve months to 838.25M, down -6.91% year-over-year. In the year 2023, Surgical Science Sweden AB had annual revenue of 882.85M with 10.01% growth.
Revenue (ttm)
838.25M
Revenue Growth
-6.91%
P/S Ratio
7.55
Revenue / Employee
3.16M
Employees
265
Market Cap
6.33B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 882.85M | 80.31M | 10.01% |
Dec 31, 2022 | 802.54M | 435.76M | 118.81% |
Dec 31, 2021 | 366.78M | 261.98M | 249.98% |
Dec 31, 2020 | 104.80M | 3.28M | 3.23% |
Dec 31, 2019 | 101.52M | 35.82M | 54.51% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |